Fig. 4From: Integrated plasma metabolomics and lipidomics profiling highlights distinctive signature of hepatocellular carcinoma in HCV patientsA–C Distribution in HCC, HCV and MC patients of A lysophosphatydilcholines (LPCs), B ether-linked lysophosphatydilcholine (LPC-O) and C phosphatydilcholine (PC), where *p-value < 0.05 and **p-value < 0.01Back to article page